Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus Coinfection-Reference-Cited by-同舟云学术

Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus Coinfection

Published:2008-01-01 Issue:1 Volume:47 Page:36-49
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Opravil Milos,Sasadeusz Joe,Cooper David A,Rockstroh Jürgen K,Clumeck Nathan,Clotet Bonaventura,Montaner Julio,Torriani Francesca J,DePamphilis Jean,Dieterich Douglas T

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference24 articles.

1. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.;Sulkowski;Clin Infect Dis,2000

2. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study.;Anderson;Clin Infect Dis,2004

3. Hepatitis C and HIV co-infection: a review.;Maier;World J Gastroenterol,2002

4. Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.;Romero;Drug Saf,2004

5. Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy.;Brau;AIDS,2003

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients;Enfermedades Infecciosas y Microbiología Clínica;2019-06

2. Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients;Enfermedades infecciosas y microbiologia clinica (English ed.);2019-06

3. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008–2015;AIDS Research and Human Retroviruses;2018-02

4. Cost-effectiveness of once-daily versus twice-daily regimens in the treatment of HIV infection in sub-Saharan Africa: a probabilistic decision model;F1000Research;2016-11-16

5. KASL clinical practice guidelines: management of hepatitis C;Clinical and Molecular Hepatology;2016-03-28